Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Gamma amino butyric acid controlled-release - Diamyd Medical

Next Previous
Drug Profile

Gamma amino butyric acid controlled-release - Diamyd Medical

Alternative Names: GABA - Diamyd; Gamma-amino-butyric-acid-Diamyd; Oral GABA Therapy - Diamyd; Remygen

Latest Information Update: 13 Sep 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Diamyd Medical AB
  • Developer Diamyd Medical AB; Uppsala University Hospital
  • Class Amines; Antihyperglycaemics; Butyric acids; Small molecules
  • Mechanism of Action GABA receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Type 1 diabetes mellitus

Most Recent Events

  • 10 May 2023 Topline adverse events data from phase I/II ReGenerate-1 trial in Type 1 diabetes mellitus released by Diamyd Medical
  • 05 Apr 2023 Before March 2023, Diamyd Medical received patent protection in the US and Japan for GABA formulation Remygen®
  • 27 Mar 2023 Pharmacokinetics data from a phase I/II trial in Diabetes mellitus released by Diamyd Medical

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top